Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection

被引：0
|
作者：
Hyungjin Kim
Kum Ju Chae
Soon Ho Yoon
Miso Kim
Bhumsuk Keam
Tae Min Kim
Dong-Wan Kim
Jin Mo Goo
Chang Min Park
机构：
[1] Seoul National University Medical Research Centre,Department of Radiology, Seoul National University College of Medicine, and Institute of Radiation Medicine
[2] Chonbuk National University Medical School and Hospital,Department of Radiology, Institute of Medical Science, and Research Institute of Clinical Medicine
[3] Seoul National University Cancer Research Institute,Department of Internal Medicine
[4] Seoul National University Hospital,undefined
来源：
European Radiology | 2018年 / 28卷
关键词：
Non-small-cell lung carcinoma; Epidermal growth factor receptor; Protein kinase inhibitor; Drug resistance; Image-guided biopsy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：861 / 868
页数：7
相关论文
共 50 条
  • [31] Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition
    Zhou, Juan
    Hu, Qiaoting
    Zhang, Xi
    Zheng, Jihua
    Xie, Bo
    Xu, Zhiyong
    Zhang, Weimin
    ONCOLOGY REPORTS, 2018, 39 (04) : 1783 - 1792
  • [32] Detection of EGFR/T790M Mutation in Advanced NSCLC Post TKI Treatment: First Experience of Liquid Biopsy in Argentina
    Mosqueira, M. C.
    Anchordoqui, S.
    Martinez Correa, R.
    Pichelbauer, E.
    Trinchero, A.
    Bianchini, M.
    Bravo, I.
    Bramuglia, G.
    Diaz Perez, I.
    Sganga, L.
    Goncalves, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S166 - S167
  • [33] Liquid biopsy for detection of EGFR T790M mutation in nonsmall cell lung cancer: An experience of proficiency testing in Taiwan
    Ho, Hsiang-Ling
    Huang, Chao-Cheng
    Ku, Wen-Hui
    Ho, Chung-Liang
    Lin, Chia-Hung
    Yu, Sung-Liang
    Chou, Teh-Ying
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (06) : 473 - 476
  • [34] Detection of the T790M Mutation of EGFR in Plasma of Advanced NSCLC Patients with Acquired Resistance to EGFR-TKI (WJOG8014LTR)
    Azuma, Koichi
    Takahama, Takayuki
    Sakai, Kazuko
    Takeda, Masayuki
    Hida, Toyoaki
    Hirabayashi, Masataka
    Oguri, Tetsuya
    Tanaka, Hiroshi
    Ebi, Noriyuki
    Sawa, Toshiyuki
    Bessho, Akihiro
    Tachihara, Motoko
    Akamatsu, Hiroaki
    Bandoh, Shuji
    Himeji, Daisuke
    Ohira, Tatsuo
    Shimokawa, Mototsugu
    Yamamoto, Nobuyuki
    Nakanishi, Yoichi
    Nakagawa, Kazuhiko
    Nishio, Kazuto
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S389 - S390
  • [35] T790M MUTATION IN PATIENTS WITH ACQUIRED RESISTANCE TO EGFR TYROSINE KINASE INHIBITORS: IS IT ASSOCIATED WITH CLINICALLY DISTINCT FEATURES?
    Ji, Jun Ho
    Sun, Jong-Mu
    Ahn, Myung-Ju
    Choi, Yoon-La
    Ahn, Jin Seok
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1073 - S1073
  • [36] First experience with osimertinib in patients with T790M mutation previously treated with EGFR TKIs in Croatia.
    Jakopovic, Marko
    Bitar, Lela
    Cucevic, Branka
    Plestina, Sanja
    Mazuranic, Ivica
    Seiwerth, Sven
    Hecimovic, Ana
    Dugac, Andrea Vukic
    Jankovic, Mateja
    Redzepi, Gzim
    Samarzija, Miroslav
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Influence of EGFR-TKIs Treatment Lines and PFS on the Emergence of T790M Mutation
    Dong, X.
    Jia, W.
    Gu, D.
    Guo, R.
    Miao, L.
    Wang, W.
    Xu, C.
    Chen, R.
    Xia, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S470 - S470
  • [38] The Clinical Usefulness of Liquid Biopsy for Detection and Dynamic Monitoring of EGFR T790M in NSCLC Patients on EGFR-TKI Therapy
    Szpechcinski, A.
    Duk, K.
    Bryl, M.
    Czyzewicz, G.
    Wojda, E.
    Florczuk, M.
    Sliwinski, P.
    Barinow-Wojewodzki, A.
    Chorostowska-Wynimko, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S803 - S803
  • [39] Correlation between EGFR mutation T790M predominancy in initial biopsy detected by droplet digital PCR and acquired resistant mechanism to EGFR TKI.
    Koba, Hayato
    Yoneda, Taro
    Nishikawa, Shingo
    Sone, Takashi
    Kimura, Hideharu
    Kasahara, Kazuo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Mechanisms of acquired resistance to osimertinib in advanced NSCLC with EGFR T790M mutation (LOGIK1607)
    Yamaguchi, Masafumi
    Osoegawa, Atsushi
    Nakamura, Tomomi
    Morinaga, Ryotaro
    Tanaka, Kentaro
    Kashiwabara, Kosuke
    Miura, Takashi
    Suetsugu, Takayuki
    Taguchi, Kenichi
    Nabeshima, Kazuki
    Kishimoto, Junji
    Sakai, Kazuko
    Nishio, Kazuto
    Sugio, Kenji
    CANCER SCIENCE, 2021, 112 : 567 - 567
12345